Presentations

Plenary sessions

Sunday, 5th October

Opening session

Welcome to the HIV and Viral Hepatitis Barcelona 2014 Conference: Objectives and expected outcomes of the conference, Brian West/José Gatell/ Jens Lundgren

José Gatell
SlidesBrian West
Slides

Jens Lundgren
Slides

Welcome address - Secretary of Public Health of the Catalan Ministry of Health, Antoni Mateu

Keynote speech: Deputy Director of Health Promotion and Epidemiology at the General Directorate of Public Health, Quality and Innovation of the Spanish Ministry of Health Social Services and Equality, The Spanish National Health and Hepatitis plan, Elena Andradas
Slides

Key note speech: European Parliament, Ernest Urtasun

European Centre for Disease Control and Prevention (ECDC) - Progress on the Dublin Declaration monitoring, Andrew Amato on behalf of Director Marc Sprenger
Slides

WHO Regional Office for Europe – WHO´s response to HIV/AIDS and viral hepatitis in the European region, Gottfried Hirnschall on behalf of Director Zsuzsanna Jakab, part 1

WHO Regional Office for Europe – WHO´s response to HIV/AIDS and viral hepatitis in the European region, Gottfried Hirnschall on behalf of Director Zsuzsanna Jakab, part 2

The patient perspective on HIV and viral hepatitis testing and linkage to care, Luís Mendão
Slides

José Gatell

Monday, 6th October
PLE1: What´s the status of the continuum of care in HIV and viral hepatitis?

The HIV and viral hepatitis epidemics in Europe: recent trends and regional differences, Jens Lundgren
Slides

Late presentation for care: the burden of disease in mono- and co-infected patients and who are the late presenters, Jürgen Rockstroh
Slides

Renewed focus on Hep C – the possibility to cure, Stanislas Pol
Slides

Linkage to care: what are the challenges?, Oksana Savenko
Slides

Key challenges in the cascade of care in the Eastern European region, Michel Kazatchkine
Slides

PLE2: Public health challenges of earlier diagnosis of HIV and viral hepatitis

PS2/01
Which Conditions are Indicators for HIV Testing across Europe?: Results from the HIDES 2 study, Galyna Kutsyna
Slides

PS2/02
European students planning to practice internal medicine are more likely to have condition-focused, rather than behaviour-focused approach to HIV testing – data from the English Division Faculty, Medical University of Warsaw, Justyna Kowalska
Slides

PS2/03
The Catalan STI Sentinel Surveillance Study Group
HIV diagnosis at time of sexually transmitted infection among men who have sex with men in Catalonia, Spain, 2011-2013, Rossie Lugo
Slides

PS2/04
Project PRO-test: Proactive HIV testing for prevention of late presentation, Ivo Joore
Slides

PS2/05
Effectiveness of a pilot partner notification program for newly diagnosed cases of HIV in Barcelona, Spain, Patricia Garcia de Olalla
Slides

PS2/06
Study Group for the Early Diagnosis of HIV in Primary Health Care in Spain
Audit on HIV Testing in patients diagnosed with a defining or related to AIDS illness and/or an indicative condition for HIV in Primary Care in Catalonia, Spain, Jordi Casabona
Slides

PLE3: Testing strategies in HV and viral hepatitis: new innovative approaches. Including civil society debate

Indicator condition guided HIV testing: what works in HIV and viral hepatitis? Implementation challenges?, Brian Gazzard
Slides

Testing of Hepatitis: Global and European perspectives, Charles Gore
Slides

Panel debate: what is the role of civil society and what are the major challenges in access to testing and care?

Eastern Europe HIV/Hepatitis, Andryi Klepikov Slides
Good Practices MSM, Ferran Pujol
Financially challenging environment, Sophocles Chanos
Testing in the Balcan states, Nenad Petkovic
Hep C testing in northern Europe, Danny Morris

Tuesday, 7th October
PLE4: Linkage to care and economic consequences - bridging lessons learned in viral hepatitis and HIV

Short report from Day 1, Brian West
Slides

Euro Hepatitis Care Index - a project of the European Liver Patients Association (ELPA), Lilyana Chavdarova
Slides

Unaffordable medicines: public health and economic consequences, Sergey Golovin
Slides

UNAIDS 90 90 90 targets – are they likely to reduce AIDS and HIV transmission? Lessons from the UK, Valerie Delpech
Slides

Late presentation of viral hepatitis for medical care: a consensus definition, Maria Buti
Slides

PLE5: Testing and linkages to care in key populations

Barriers to access testing, treatment and care for key populations, Ramón Esteso
Slides

Challenges of HCV testing in people who inject drugs, Jason Farrell
Slides

Migrants in Europe: a rising epidemic of undiagnosed?, Manuel Carballo
Slides

Increasing incidence of HIV and HCV among MSM across Europe, Ulrich Marcus
Slides

Closing session

Short report from Day 2, Brian West Slides

Joint statement on the future collaboration between HIV and viral hepatitis groups on earlier testing and care, Jens Lundgren & Andrew Amato Call for action draft

Debate: What can we learn from each other?

ECDC, Andrew Amato
WHO Regional Office for Europe, Martin Donoghoe
Correlation hepatitis C Initiative, Eberhard Schatz
ELPA, Margaret Walker
EASL, Stefan Mauss
World Hepatitis Alliance, Charles Gore
HEPBCPPA, Angelos Hatzakis
The HIV in Europe Initiative, Brian West
UNAIDS, Jean-Elie Malkin

Parallel sessions
Monday, 6th October
PS1: Late presentation

PS1/01
Continued late presentation for HIV care across Europe, Amanda Mocroft
Slides

PS1/02
Challenges in the definition of ‘Late presentation to HIV testing’, André Sasse

PS1/03
Undiagnosed HIV and Hepatitis C infection among people who inject drugs, Cinta Folch
Slides

PS1/04
The SIALON Project: Undiagnosed HIV Infection among MSM in Six Southern and European Cities, Laia Ferrer
Slides

PS1/05
BCN Checkpoint: 31% of the new HIV cases detected in a Community-Based Center for MSM are recent infections, Michael Meulbroek
Slides

PS1/06

Reaching the undiagnosed: a collaborative project, Magdalena Harris
Slides

PS2: Testing in health care settings

PS3/01
Impact of immigration on diagnosis and prognosis of HIV in Catalonia and the Balearic Islands: The PISCIS Cohort, Manuel Fernández Quevedo
Slides

PS3/02
Athens Checkpoint: Reducing Undiagnosed HIV Infections in Crisis-Affected Services in Greece, Sophocles Chanos
Slides

PS3/03
Expert recommendations for the information and support needs of different population groups in preparation for 2014 government approval for HIV self-testing in France, Karen Champenois
Slides

PS3/04
Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection?, Sandra Manzanares-Laya
Slides

PS3/05
Hepatitis B: are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries, Miriam Levi
Slides

PS3/06
Socio-demographical and behavioral characteristics of Men who have sex with Men (MSM) attending a voluntary counseling and testing (VCT) centre in Brussels, Anne-Françoise Gennotte
Slides

Tuesday, 7th October
PS4: Key populations 2

PS4/01
HIV testing trends among MSM in Croatia: review of surveys conducted from 2005 to 2012, Zoran Dominkovic
Slides

PS4/02
Serving the underserved. An HIV testing program for populations reluctant to attend conventional settings, Ramón Esteso
Slides

PS4/03
Results of a disease awareness programme offering Chinese migrants on-site testing for chronic hepatitis B and C virus infection in six urban areas in the Netherlands, Irene Veldhuijzen
Slides

PS4/04
Determinants of having never been tested for HIV amongst migrant men who have sex with men in Spain, Percy Fernández-Dávila
Slides

PS4/05
Characteristics of Foreign-Born Patients in the Swiss Hepatitis C Cohort Study: Implications for National Screening Recommendations, Barbara Bertisch
Slides

PS5: The treatment cascade

PS5/01
Continuum of care of the patients diagnosed with HIV in Belgium according to region of origin, Dominique Van Beckhoven
Slides

PS5/02
Peer education at infectious diseases units as a mechanism to optimize the left side steps of the HIV treatment cascade, Antonio R. G. Susperregui
Slides

PS5/03
Regional differences in hepatitis testing, vaccination and treatment in the EuroSIDA study, Jeffrey Lazarus
Slides

PS5/04
Exploring how Commonly Diagnosing Services Refer Newly Diagnosed Chronic Hepatitis B and C Patients to Specialist Secondary Care: The Views of Hepatologists, Gastroenterologists and Infectious Diseases Specialists in Six EU Countries, Miriam Levi
Slides

PS5/05
Evidence for the cost-effectiveness of screening for chronic hepatitis B and C among migrant populations: results from a review of the literature, Susan Hahné
Slides

PS6: Alternative approaches

PS6/01
Home delivered Dried blood spot testing vs conventional follow up - Assessing the impact on screening uptake for Household contacts of Hepatitis B infected pregnant women across two London trusts, Philip Keel
Slides

PS6/02
Pilot HCV rapid testing project among men who have sex with men (MSM), CheckList Project, Lisbon, Portugal, Miguel Rocha
Slides

PS6/03
Feasibility of joint HIV, HBV and HCV testing offered routinely by general practitioners during one week in two French counties in 2012, Catherine Fagard
Slides

PS6/04
Screening for viral hepatitis among immigrants in Barcelona: Comparison of two recruitment strategies. A pilot study of the HEPscreen Project, Manuel Fernández Quevedo
Slides

PS6/05
Health service-based HIV testing and counselling: a review of European guidelines, Stephen Bell
Slides

Posters

PO1/PS1: Late presentation

PO1/01 HCV Infection in HIV-infected Individuals in Ukraine

PO1/02 Previous Sexually Transmitted Infection among Young Men who Have Sex with Men as a Determinant for Earlier HIV Diagnosis in Catalonia

PS1/01 Continued Late Presentation for HIV Care across Europe

PS1/02 Challenges in the Definition of 'Late Presentation to HIV Testing'

PS1/03 Undiagnosed HIV and Hepatitis C Infection among People who Inject Drugs

PS1/04 The SIALON Project: Undiagnosed HIV Infection among MSM in Six Southern and European Cities

PS1/05 BCN Checkpoint: 31% of the New HIV Cases Detected in a Community-based Center for MSM Are Recent Infections

PS1/06 Reaching the undiagnosed: a collaborative project

PO2/PS2: Testing in health care settings

PO2/01 HIV Testing in the Emergency Department Is Sustainable and Low Cost

PO2/02 Investigating Barriers in HIV-testing Oncology Patients. The IBITOP Study: Phase I

PO2/03 Prevalence of HIV Infection and Acceptability of Rapid HIV Testing in Patients Attending Emergency Services

PO2/04 HIV Testing Uptake and Associated Factors among Sex Workers in Portugal

PO2/06 Management of Routine HIV Testing through Voluntary Counseling and Testing Services among TB-positive Patients in Ukraine

PO2/07 Human Immunodeficiency Virus (HIV) Testing among Childbearing Aged Women: who is at risk?

PS2/01 Which Conditions are Indicators for HIV Testing across Europe?: Results from the HIDES 2 study

PS2/02 European students planning to practice internal medicine are more likely to have condition-focused, rather than behaviour-focused approach to HIV testing - data from the English Division Faculty, Medical University of Warsaw

PS2/03 HIV Diagnosis at Time of Sexually Transmitted Infection among Men who Have Sex with Men in Catalonia, Spain, 2011-2013

PS2/04 Project PRO-test: Proactive HIV Testing for Prevention of Late Presentation

PS2/05 Effectiveness of a Pilot Partner Notification Program for Newly Diagnosed Cases of HIV in Barcelona, Spain

PS2/06 Audit on HIV Testing in Patients Diagnosed with a Defining or Related to AIDS Illness and/or an Indicative Condition for HIV in Primary Care in Catalonia, Spain